Also on this list
Embody
Low sale prices and four named pharmacies, but every payment is final.
Another provider on our sermorelin provider ranking.
Read the Embody review →
Provider review
Strut Health lists sermorelin at $119/mo, tirzepatide at From $149/mo and semaglutide at From $149/mo, plus 1 more below. Prices checked October 2026.
Every published price is an auto-refill price; a single order is never priced.
FDA's February 2026 letter cites Strut's own site for marketing compounded tirzepatide and semaglutide as "Generic Zepbound, Mounjaro." Separately, every product page leads with an auto-refill price and a "Save" badge, but none prints the price you pay without auto-refill.
Transparency scorecard
2 of 4 disclosed openly
What Strut Health discloses about itself, read from its own pages — not estimated.
Pharmacy category stated
Not disclosed
States no federal regulatory category (503A/503B) for its pharmacy on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. A commission does not change what a review says. Full disclosure here.
Also on this list
Embody
Low sale prices and four named pharmacies, but every payment is final.
Another provider on our sermorelin provider ranking.
Read the Embody review →| Compound | Advertised | What you pay monthly | Pharmacy | Checked |
|---|---|---|---|---|
| Sermorelin | $119/mo | $119/mo | Not disclosed | October 2026 |
| Tirzepatide | From $149/mo | From $149/mo | Not disclosed | October 2026 |
| Semaglutide | From $149/mo | From $149/mo | Not disclosed | October 2026 |
| NAD+ | $149/mo | $149/mo | Not disclosed | October 2026 |
What this price covers
Medication
Included
Provider visits
Included
Shipping
Not confirmed
Lab work
Not disclosed
Coaching
Not disclosed
The catch — Auto-refill enrollment. Each "Save" badge implies a higher price for a single order, but that price is not published anywhere on the product pages.
See plans at Strut HealthPrices read from Strut Health's own site
What they advertise
Every product page leads with an "Auto Refill" price: $149/mo "As low as, Save 14%" for injectable tirzepatide, $199/mo "Save 17%" for oral tirzepatide, $149/mo "Save 13%" for injectable semaglutide, $99/mo "Save 21%" for oral semaglutide, $119/mo for injectable sermorelin, $99/mo for the sermorelin lozenge, and $149/mo for one 500mg vial of NAD+.
What you actually pay
Tirzepatide is $149 a month injectable or $199 oral on auto-refill; the page's second "30 DAY SUPPLY" panel repeats the same figure. Semaglutide is $149 a month injectable or $99 oral. Sermorelin is $119 a month injectable or $99 as a lozenge. NAD+ is $149 a month. None of these pages prints a price without auto-refill. Strut's blog says "all auto-refills are discounted by 21%," while the badges on its own product pages range from 13% to 21%.
Money you will meet later
Strut Health, LLC (Dallas, TX; founder Dr. Simal Patel) sells compounded tirzepatide and semaglutide, each as an injection or an oral lozenge, plus compounded sermorelin (injection or lozenge) and NAD+ injections. Its FAQ says it ships to "all states except for Arkansas." Two things pull against it. First, FDA sent Strut Health, LLC a warning letter (MARCS-CMS 721448, February 20, 2026) over product labels pictured on its site that put "Strut" on the vial as though Strut compounded the drugs — it doesn't — and over claims such as "Generic Zepbound, Mounjaro," which FDA says falsely imply an FDA approval a compounded drug has never had. Neither the phrase nor a "Strut"-branded label appears on its weight-loss or peptide product pages in October 2026; the tirzepatide vial now reads only "TIRZEPATIDE / MEDICAL WEIGHT MANAGEMENT COMPOUNDED MEDICATION / PRESCRIPTION ONLY." Second, every price is an auto-refill price: $149/mo "As low as" for injectable tirzepatide ("Save 14%"), $199/mo for the oral lozenge ("Save 17%"), $149/mo for injectable semaglutide, $119/mo for injectable sermorelin and $149/mo for NAD+. A "Save" badge implies a higher price without auto-refill, but no product page prints it.
Strut Health appears on our sermorelin provider ranking, our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking and our combined weight loss injections ranking.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Strut Health states no 503A/503B category for the pharmacy that fills your prescription.
No pharmacy is named anywhere on the site, and neither "503A" nor "503B" appears. The semaglutide page says Strut "only works with U.S.-licensed sterile and non-sterile compounding pharmacies," and its Telemedicine Consent refers to an unnamed "Strut Health's partner pharmacy." Prescriptions are written by Titan Medical Group's physicians, not by Strut. Its sign-up names no pharmacy either: after the medical questions it asks for identity verification against a government ID before the cart, so the pharmacy can't be learned before that step.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
49 states: the FAQ says, "As of September 2024, we can ship to all states except for Arkansas. Certain medications may not be available in all states." Its sign-up confirms it today, asking you to confirm you don't live in Arkansas before anything else.
The part they would rather you skipped
FDA sent Strut Health, LLC a warning letter (MARCS-CMS 721448, February 20, 2026, Center for Drug Evaluation and Research), addressed to "Simal Patel, MD, Chief Executive Officer" at the same Dallas address Strut publishes. FDA reviewed the site in December 2025 and found two problems. One: "The compounded semaglutide and tirzepatide products displayed on your website identify 'Strut' on the pictured label, suggesting Strut is the compounder of those drugs when in fact it is not." Two: the site carried "Generic Zepbound, Mounjaro" and "Tirzepatide is the active ingredient in the brand medications Zepbound® and Mounjaro®" — claims FDA says falsely imply an FDA approval and safety review a compounded drug has never had, misbranding under FDCA §502(a) and §502(bb). In October 2026, neither "Zepbound" nor "Mounjaro" appears on Strut's tirzepatide, semaglutide, sermorelin or NAD+ product pages, the tirzepatide vial carries no brand name, and the small print says, "Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA." That is real cleanup on the pages a buyer sees, but the letter stands on FDA's record.
Other providers on our sermorelin provider ranking — the closest match to what Strut Health sells.




109 more providers are on our sermorelin provider ranking — see the full list. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Ready to get started?
Prices and plans in this category change often — check Strut Health's current pricing before you decide. Ours was read from their own site.
Facts on this page reflect Strut Health's own public disclosures when we last checked them. Prices and terms change without notice — confirm on Strut Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.
Strut Health
4 compounds from $119/mo